Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The...
About Metaverse Dualchain Network Architecture (DNA)
Launched on 09/09/2019, Metaverse Dualchain Network Architecture aims to form a parallel cross-chain structure with ETP to incorporate speed and security on the network, presenting a solution to the impossible trinity.
The low is in for DNABTC (Metaverse) since late last year... We are witnessing a...
Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in.
The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma.
An appropriate level to exit the trade then, would be below the 50sma.
There also horizontal support as we fill the gap.
$EXAS is looking strong with a potentially good entrance for a gap up.
BUY signal with 8 confirmations.
Happy Trading, from CJ -- aka the greatest FURU.
To find out more about The Ultimate Stock Indicator on Tradingview, please check my public profile.
Alright team i want you to keep this channel in mind as we progress through another Green Week!
I am predicting this price will maintain within this channel moving forward.
As you can see now it is doing a good job staying within !
Penny stocks are always volatile. However The revolutionary technology this company is bringing to the table is outstanding
I am sure...
Illumina is the worldwide leader in genetic sequencing.
Illumina's earnings over the next few years are expected to double, indicating a very optimistic future ahead.
With less than 0.02% of humans having been sequenced and 99% of the variants discovered in the genome having not yet been deciphered, Illumina, at only $3.4 billion of TTM revenue, is still in its...
Beam Therapeutics develops and commercializes DNA base editing technologies for the treatment of human disease.
Beam Therapeutics Presents First Data Highlighting Base Editing Program For Glycogen Storage Disease Type Ia At AASLD (Nov 13 Reuters).
The indicators are bearish right now. I am looking for a strong retracement to long this stock!
The market cap is...
Zoom in to find out more .
Target point comes from Parent Trend DNA
Accumulation point is a result of three different analysis (fib ret ,fib spiral , lower boarder of main trend channel )
if you find it useful plz like or share . comments for more idea .
BTW today analysis is not against the main trend analysis from previous job , its just covering market...
Advance Harmonic Trading BTC/USD
we have traced three different harmonic bullish patterns,
Green one which is the biggest cover area from DEC 2017 until October 2020
we name it Parent pattern be cos of wide area of coverage. (helps with finding Future target point).
second one which is pink covers area from Jun 2019 till Jun 2020. (helps current...
Not giving closer analysis on this stock.
Quick TA view:
Time cycles seem to match quite closely to the drops indicating unrest with stockholders during close to monthly cycles with roughly weeks recoveries to previous levels. We're still well within the trend line set in early 2017's. Two larger scale cup and handles have taken the price back to the trend...
DAN is a nice smart money short setup with significant insider selling. It also has great Money flow divergence. We think it has strong downside potential if it can break 26.90 level.
To play this we would consider $27 June Puts
* Trade Criteria *
Date First Found- February 27, 2018
Pattern/Why- Smart money momentum short setup
Entry Target Criteria- Break...